Cytori Therapeutics (CYTX) Celution is cost-effective for Partial Breast Reconstruction
May 31st, 2011
No comments
An economic analysis carried out by the UK NHS National Innovation Centre identified CYTX’s Celution® System for breast reconstruction Read more…
Categories: Cytori Therapeutics, NASDAQ: CYTX, UK NHS National Innovation Centre
